The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
postMONARCH: A phase 3 study of abemaciclib plus fulvestrant versus placebo plus fulvestrant in patients with HR+, HER2-, metastatic breast cancer following progression on a CDK4 & 6 inhibitor and endocrine therapy.
 
Kevin Kalinsky
Stock and Other Ownership Interests - Array BioPharma (I); GRAIL (I); Pfizer (I)
Consulting or Advisory Role - 4D Pharma; AstraZeneca; bioTheranostics; Cyclacel; Daiichi Sankyo/Astra Zeneca; Eisai; Genentech/Roche; immunomedics; Ipsen; Lilly; Merck; mersana; Novartis; Oncosec; pfizer; Puma Biotechnology; Seagen
Speakers' Bureau - Lilly
Research Funding - Acetylon Pharmaceuticals (Inst); Amgen (Inst); Calithera Biosciences (Inst); CytomX Therapeutics (Inst); Genentech/Roche (Inst); Immunomedics (Inst); incyte (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Zeno Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Pfizer
Other Relationship - Genentech; Immunomedics
 
Rachel M. Layman
Consulting or Advisory Role - Celcuity; Celcuity; Celcuity; GE Healthcare (I); Lilly; Novartis; Siemens (I)
Research Funding - Celcuity; Genentech (Inst); GlaxoSmithKline (Inst); Ipsen (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Zentalis (Inst)
(OPTIONAL) Uncompensated Relationships - Lilly
 
Peter A. Kaufman
Stock and Other Ownership Interests - Amgen
Honoraria - Eisai; Lilly; Macrogenics; Polyphor
Consulting or Advisory Role - AstraZeneca; Eisai; Lilly; Macrogenics; Merck; Pfizer; Polyphor; Roche/Genentech
Speakers' Bureau - Lilly
Research Funding - Eisai (Inst); Lilly (Inst); Macrogenics (Inst); Novartis (Inst); Pfizer (Inst); Polyphor (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Lilly; Macrogenics; Polyphor
 
Stephanie L. Graff
Stock and Other Ownership Interests - HCA Healthcare
Honoraria - Publicis Health
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Lilly; Genentech; Novartis; Novartis (Inst); Pfizer; Seagen (Inst)
Speakers' Bureau - OncLive
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Daiichi Sankyo (Inst); Dana Farber Cancer Hospital (Inst); Eisai (Inst); Foundation Medicine (Inst); Genentech (Inst); GRAIL (Inst); H3 Biomedicine (Inst); Immunomedics (Inst); Innocrin Pharma (Inst); Lilly (Inst); Merck (Inst); Merus NV (Inst); Novartis (Inst); Odonate Therapeutics (Inst); Polyphor (Inst); Roche (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst); TapImmune Inc. (Inst)
 
Giampaolo Bianchini
Honoraria - AstraZeneca/Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Roche Molecular Diagnostics; Seagan
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; Novartis; Pfizer; Roche
 
Miguel Martin
Honoraria - Lilly; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Seagen
Consulting or Advisory Role - AstraZeneca; Daiichi-Sankyo; Lilly; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - Lilly/ImClone; Lilly/ImClone; Pierre Fabre; Roche/Genentech
Research Funding - Novartis (Inst); Puma Biotechnology (Inst); Roche (Inst)
Other Relationship - Novartis; Roche
 
Yanhong Zhou
No Relationships to Disclose
 
Holly Knoderer
Stock and Other Ownership Interests - Lilly
 
Lacey Litchfield
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Seth Andrew Wander
Consulting or Advisory Role - Biovica; Foundation Medicine; Hologic; Lilly; Pfizer; Puma Biotechnology; Veracyte
Research Funding - Genentech